These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Diffuse alveolar damage syndrome associated with amiodarone therapy.
    Author: Jirik FR, Henning H, Huckell VF, Ostrow DV.
    Journal: Can Med Assoc J; 1983 May 15; 128(10):1192-5. PubMed ID: 6839242.
    Abstract:
    Amiodarone is an effective antiarrhythmic that has been used in Europe for over a decade and has been available for investigational use in North America for a shorter time. It has several well recognized side effects. Recent reports have related pulmonary disorders to the use of this drug; fibrosing alveolitis has been found by lung biopsy. Amiodarone's toxicity to the lung does not appear to be dose-related. Besides cessation of amiodarone administration, management of this complication includes steroid therapy. A case is described of nonspecific diffuse alveolar damage syndrome in a patient who had received amiodarone.
    [Abstract] [Full Text] [Related] [New Search]